Skip to main content

Yakult Honsha Co.,Ltd. (2267.T)

Japan Exchange Group Consumer Defensive Beverages - Non-AlcoholicView data quality →
59.7Fair

ValueMarkers Composite Index

Top 77%#10,461 of 44,707
Undervalued

54% below intrinsic value ($39)

UndervaluedFair ValueOvervalued
Piotroski
5/9
Neutral
Beneish
-2.86
Low Risk
Altman
3.96
Safe
DCF Value
$39
Undervalued
ROIC
4.0%
Low
P/E
17.7
Fair
Updated: ·Source: Data sourced from SEC filings and institutional providers. Not financial advice.·Report data issue

Yakult Honsha Co.,Ltd. (2267.T) — VMCI valuation read

Across 120 indicators, Yakult Honsha Co.,Ltd. (2267.T) lands at VMCI 60/100. The Consumer Defensive sector median is 50, so the 10-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.

No material Form 4 disclosures landed on 2267.T in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.

**Investor frame.** On Value, 2267.T trades at 15.0x earnings, 17% below the Consumer Defensive median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Consumer Defensive median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of 0.0x leaves covenant headroom for 2267.T on the trailing balance sheet.

2267.T rose 3.8% over the trailing 7 days, with a -20.6% read on a 30-day basis.

Yakult Honsha Co.,Ltd. manufactures and sells food and beverage products, cosmetics, pharmaceuticals, and others. It operates through Food and Beverages (Japan), Food and Beverages (The Americas), Food and Beverages (Asia and Oceania), Food and Beverages (Europe), Pharmaceuticals, and Others segments. The company offers fermented milk drinks, juices, noodles, etc. through its home delivery and retail store channels. It also provides pharmaceutical products, such as Elplat, an antineoplastic drug, as well as generic anti-cancer agents, including Gemcitabine Yakult, Capecitabine, and Gefitinib Yakult tablets. In addition, the company offers cosmetics; and operates the Tokyo Yakult Swallows, a professional baseball team. Yakult Honsha Co.,Ltd. was founded in 1935 and is headquartered in Tokyo, Japan.

CEO: Hiroshi Natsume29,627 employeesJPwww.yakult.co.jp

Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.

Browse More

Key metrics explained

Definitions, formulas, and how ValueMarkers calculates each indicator used in 2267.T’s VM Score.

Explore More

Compare Competitors

Weekly Stock Analysis - Free

5 undervalued stocks, fully modeled. Every Monday. No spam.

Cookie Preferences

We use cookies to analyze site usage and improve your experience. You can accept all, reject all, or customize your preferences.